Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MYOS

MYOS RENS Technology (MYOS) Stock Price, News & Analysis

About MYOS RENS Technology Stock (NASDAQ:MYOS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.01
$11.40
52-Week Range
N/A
Volume
N/A
Average Volume
1.68 million shs
Market Capitalization
$16.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MYOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS RENS Technology and its competitors with MarketBeat's FREE daily newsletter.

MYOS Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Bio-active Peptides Market Size Dynamics 2023-2029
See More Headlines

MYOS Stock Analysis - Frequently Asked Questions

MYOS RENS Technology Inc. (NASDAQ:MYOS) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The company had revenue of $0.15 million for the quarter, compared to analyst estimates of $0.14 million. MYOS RENS Technology had a negative trailing twelve-month return on equity of 166.68% and a negative net margin of 277.82%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
8/06/2019
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MYOS
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.26 million
Net Margins
-277.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.03 million
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$16.70 million
Optionable
Not Optionable
Beta
1.08
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MYOS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners